Michael R. MacDonald

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Michael R. MacDonald, Mark C. Petrie, Fumi Varyani et al. · European Heart Journal · 2008 · 698 citations · Full text

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

Michael R. MacDonald, Derek T. Connelly, Nathaniel M. Hawkins et al. · Heart · 2010 · 340 citations

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 316 citations

Metabolic Syndrome, Glucose Tolerance, Diabetes Management +10

Improving patient survival with the colorectal cancer multi‐disciplinary team

Ewan MacDermid, Georgia Hooton, Michael R. MacDonald et al. · Colorectal Disease · 2008 · 212 citations

Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry

Carolyn S.P. Lam, Tiew‐Hwa Katherine Teng, Wan Ting Tay et al. · European Heart Journal · 2016 · 195 citations · Full text